|
Volumn 39, Issue 3, 2012, Pages 271-272
|
Carbapenem-resistant Pseudomonas aeruginosa pneumonia with intermediate minimum inhibitory concentrations to doripenem: Combination therapy with high-dose, 4-h infusion of doripenem plus fosfomycin versus intravenous colistin plus fosfomycin
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CARBAPENEM;
COLISTIN;
DORIPENEM;
FOSFOMYCIN;
IMIPENEM;
MEROPENEM;
ADULT;
ANTIBIOTIC RESISTANCE;
BACTERIAL PNEUMONIA;
BACTERIUM CULTURE;
CLINICAL ARTICLE;
CONTROLLED STUDY;
CREATININE CLEARANCE;
DRUG ERUPTION;
DRUG MEGADOSE;
DRUG RESPONSE;
FEMALE;
HOSPITAL INFECTION;
HUMAN;
KIDNEY FAILURE;
LETTER;
MALE;
MINIMUM INHIBITORY CONCENTRATION;
NEUROLOGIC DISEASE;
PRIORITY JOURNAL;
PSEUDOMONAS AERUGINOSA;
PSEUDOMONAS INFECTION;
RETROSPECTIVE STUDY;
SIDE EFFECT;
THAILAND;
TREATMENT OUTCOME;
UNSPECIFIED SIDE EFFECT;
VENTILATOR ASSOCIATED PNEUMONIA;
CARBAPENEMS;
COLISTIN;
CROSS INFECTION;
DRUG RESISTANCE, BACTERIAL;
DRUG THERAPY, COMBINATION;
FEMALE;
FOSFOMYCIN;
HUMANS;
INFUSIONS, INTRAVENOUS;
MALE;
MICROBIAL SENSITIVITY TESTS;
MIDDLE AGED;
PNEUMONIA, VENTILATOR-ASSOCIATED;
PSEUDOMONAS AERUGINOSA;
RETROSPECTIVE STUDIES;
TIME FACTORS;
|
EID: 84857055605
PISSN: 09248579
EISSN: 18727913
Source Type: Journal
DOI: 10.1016/j.ijantimicag.2011.11.012 Document Type: Letter |
Times cited : (46)
|
References (5)
|